Mountain gorillas live in one of the most medically precarious situations of any wild animal. They are genetically close enough to humans that virtually every pathogen capable of infecting a human is also capable of infecting a gorilla. They live in forest environments shared, at the margins, with human farming communities where domestic animals and wildlife intersect. And the conservation activities designed to protect them — habituating gorillas to human presence, conducting veterinary interventions, bringing researchers and tourists to within metres of the animals — necessarily create exposure pathways that would not exist for truly isolated wild populations. Understanding how gorillas maintain health in this context, and what the science of their immune systems reveals, is central to understanding both the risks they face and the strategies used to mitigate them.
Shared susceptibility: the risk of human pathogens
The genomic similarity between humans and mountain gorillas — approximately 98.4 percent shared DNA — translates directly into shared receptor sites for respiratory viruses, similar antibody production pathways, and susceptibility to the same bacterial, viral, and parasitic infections. Studies comparing immune gene sequences have confirmed that mountain gorillas carry functional versions of the immune system components that humans use to fight respiratory viruses, enteric pathogens, and a range of other infectious agents.
Respiratory infections represent the most acute threat. Upper respiratory disease outbreaks in habituated gorilla groups have been documented multiple times across Bwindi and the Virunga Massif, and genetic analysis of infecting pathogens has in several cases identified strains consistent with human respiratory viruses. A 2009 outbreak in Bwindi affected multiple gorillas in a habituated group; respiratory disease was also implicated in the 2011 death of a young Bwindi gorilla, with genetic analysis suggesting the infecting pathogen was related to human paramyxovirus.
The gorilla population’s small size amplifies this risk considerably. When a respiratory pathogen enters a human community, even a high mortality rate affects only a fraction of the billions of potential hosts globally. When the same pathogen enters a mountain gorilla population of 1,100 individuals — many of them in discrete, small groups — a single outbreak can affect a meaningfully large percentage of the entire global population. The 2011 death affected a family of 12 gorillas; if two or three members had died, the demographic impact on the population as a whole would have been significant.
Natural immune defenses
Despite their vulnerability to human pathogens, mountain gorillas also possess robust immune capabilities shaped by millions of years of co-evolution with their forest environment. Their immune systems are experienced with the full range of tropical forest pathogens — parasitic worms, protozoa, bacteria, and viruses native to the montane forest ecosystem — and maintain active immune responses against this background of endemic infection.
Research on gorilla parasite loads has found that wild mountain gorillas carry a range of intestinal parasites — nematodes, protozoans including Giardia — at levels that would be considered clinically significant in humans but that appear to cause minimal health impact in healthy wild gorillas. This suggests a degree of co-evolutionary accommodation: the gorilla immune system manages these endemic parasites rather than eliminating them, a strategy that conserves immune resources for more acute threats.
Stress hormones — particularly cortisol — are known to suppress immune function in primates, and research has documented elevated cortisol in gorilla groups during periods of habitat disturbance, social disruption, or heavy human activity near their range. This immune suppression under stress is directly relevant to conservation management: gorilla families that experience frequent disturbance may be more susceptible to disease transmission than those in stable, low-disturbance environments. This is one reason why careful management of tourist numbers, trekking frequencies, and behaviour rules around gorilla families is not simply about animal welfare in the abstract — it has measurable health implications.
Veterinary intervention: the Gorilla Doctors
The Mountain Gorilla Veterinary Project — now operating as Gorilla Doctors — was established in 1986 to provide veterinary care for habituated gorilla populations in Uganda, Rwanda, and DRC. The programme has conducted hundreds of medical interventions over its history, treating snare wounds, respiratory infections, eye injuries, and other conditions that would likely have been fatal without treatment.
The decision to intervene veterinarily in a wild animal population is not straightforward. Arguments against intervention emphasise that it undermines the naturalness of wild populations, that anaesthesia and handling carry their own risks, and that selecting which individuals to treat and which to leave creates value judgments that are difficult to make consistently. Arguments for intervention — which the Gorilla Doctors programme has embraced — emphasise that the mountain gorilla population is so small that individual lives have demographic significance, that the causes of many gorilla health crises are anthropogenic (snares set by humans, pathogens transmitted from humans), and that it is ethically inconsistent to cause harm through tourism and research activities while declining to help individuals those activities put at risk.
Vaccination is another intervention tool being developed for mountain gorilla conservation. Vaccines against measles, human metapneumovirus, and other respiratory pathogens have been tested in captive great apes and show promise for wild populations. The logistical challenge of vaccinating wild gorillas — capturing or darting individuals in dense forest for a medical procedure that they will experience as threatening — limits the scope of vaccination programmes, but targeted vaccination of highest-risk individuals (those in heavily visited groups, those with known exposure to human diseases) is increasingly feasible.
COVID-19 and great apes
The SARS-CoV-2 pandemic that began in 2020 created immediate and serious concern for mountain gorilla conservation. Early studies confirmed that the ACE2 receptor — the human cell protein through which SARS-CoV-2 enters human cells — has a virtually identical structure in great apes, suggesting that COVID-19 would be as infectious and potentially as dangerous for gorillas as for humans. This concern was not theoretical: in January 2021, a group of gorillas at San Diego Zoo tested positive for SARS-CoV-2, with several individuals showing respiratory symptoms.
In response, both Uganda and Rwanda suspended gorilla trekking for extended periods during the pandemic and implemented strict COVID testing and PPE requirements when trekking resumed. The rules requiring trekkers to wear face masks within 10 metres of gorillas, established during the pandemic, have remained in place at varying enforcement levels as a permanent modification to trekking protocols. Whether wild mountain gorilla populations experienced COVID-19 infections during the pandemic remains unknown — the surveillance capacity to detect respiratory infections in non-habituated forest groups is limited — but no confirmed outbreaks in wild populations were reported.
Practical implications for visitors
The gorilla health protocols that can feel bureaucratic during the briefing — the seven-metre distance rule, mask requirements, the instruction not to trek if you have a cold or flu symptoms — exist because of everything described above. Each visitor is a potential disease vector, and the accumulated risk across 50,000 or more annual visitors to habituated gorilla families is not trivial. Following these rules precisely, every time, without exception, is not simply compliance with park regulations; it is a direct contribution to the health and survival of the animals you came to see. That is worth understanding and worth taking seriously.
